BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12962153)

  • 41. Medium-chain acyl-CoA dehydrogenase deficiency in gene-targeted mice.
    Tolwani RJ; Hamm DA; Tian L; Sharer JD; Vockley J; Rinaldo P; Matern D; Schoeb TR; Wood PA
    PLoS Genet; 2005 Aug; 1(2):e23. PubMed ID: 16121256
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.
    Ide T; Shimano H; Yoshikawa T; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Yatoh S; Iizuka Y; Tomita S; Ohashi K; Takahashi A; Sone H; Gotoda T; Osuga J; Ishibashi S; Yamada N
    Mol Endocrinol; 2003 Jul; 17(7):1255-67. PubMed ID: 12730332
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased dietary fat contributes to dysregulation of the LKB1/AMPK pathway and increased damage in a mouse model of early-stage ethanol-mediated steatosis.
    Shearn CT; Smathers RL; Jiang H; Orlicky DJ; Maclean KN; Petersen DR
    J Nutr Biochem; 2013 Aug; 24(8):1436-45. PubMed ID: 23465594
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The gene encoding acyl-CoA-binding protein is subject to metabolic regulation by both sterol regulatory element-binding protein and peroxisome proliferator-activated receptor alpha in hepatocytes.
    Sandberg MB; Bloksgaard M; Duran-Sandoval D; Duval C; Staels B; Mandrup S
    J Biol Chem; 2005 Feb; 280(7):5258-66. PubMed ID: 15611101
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential induction of genes in liver and brown adipose tissue regulated by peroxisome proliferator-activated receptor-alpha during fasting and cold exposure in acyl-CoA dehydrogenase-deficient mice.
    Goetzman ES; Tian L; Wood PA
    Mol Genet Metab; 2005 Jan; 84(1):39-47. PubMed ID: 15639194
    [TBL] [Abstract][Full Text] [Related]  

  • 46. GATA factors lie upstream of Nkx 2.5 in the transcriptional regulatory cascade that effects cardiogenesis.
    Brewer AC; Alexandrovich A; Mjaatvedt CH; Shah AM; Patient RK; Pizzey JA
    Stem Cells Dev; 2005 Aug; 14(4):425-39. PubMed ID: 16137232
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of the CREB-binding protein/p300-interacting protein CITED2 as a peroxisome proliferator-activated receptor alpha coregulator.
    Tien ES; Davis JW; Vanden Heuvel JP
    J Biol Chem; 2004 Jun; 279(23):24053-63. PubMed ID: 15051727
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Loss of the Mitochondrial Fatty Acid β-Oxidation Protein Medium-Chain Acyl-Coenzyme A Dehydrogenase Disrupts Oxidative Phosphorylation Protein Complex Stability and Function.
    Lim SC; Tajika M; Shimura M; Carey KT; Stroud DA; Murayama K; Ohtake A; McKenzie M
    Sci Rep; 2018 Jan; 8(1):153. PubMed ID: 29317722
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor alpha (ERRalpha).
    Schreiber SN; Knutti D; Brogli K; Uhlmann T; Kralli A
    J Biol Chem; 2003 Mar; 278(11):9013-8. PubMed ID: 12522104
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of peroxisome proliferator-responsive human genes by elevated expression of the peroxisome proliferator-activated receptor alpha in HepG2 cells.
    Hsu MH; Savas U; Griffin KJ; Johnson EF
    J Biol Chem; 2001 Jul; 276(30):27950-8. PubMed ID: 11371553
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro correction of medium chain acyl CoA dehydrogenase deficiency with a recombinant adenoviral vector.
    Schowalter DB; Matern D; Vockley J
    Mol Genet Metab; 2005 Jun; 85(2):88-95. PubMed ID: 15896652
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An analysis on transcriptional regulation activity of human XBP1 gene 5' upstream DNA sequences.
    Guo FJ; Cheng HE; Yi FP; Peng HM; Song FZ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Feb; 23(1):1-6. PubMed ID: 16456775
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The sudden infant death syndrome gene: does it exist?
    Opdal SH; Rognum TO
    Pediatrics; 2004 Oct; 114(4):e506-12. PubMed ID: 15466077
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting.
    Kersten S; Seydoux J; Peters JM; Gonzalez FJ; Desvergne B; Wahli W
    J Clin Invest; 1999 Jun; 103(11):1489-98. PubMed ID: 10359558
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 6-Phosphofructo-2-kinase (pfkfb3) gene promoter contains hypoxia-inducible factor-1 binding sites necessary for transactivation in response to hypoxia.
    Obach M; Navarro-Sabaté A; Caro J; Kong X; Duran J; Gómez M; Perales JC; Ventura F; Rosa JL; Bartrons R
    J Biol Chem; 2004 Dec; 279(51):53562-70. PubMed ID: 15466858
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of fatty acids on mitochondrial beta-oxidation enzyme gene expression in renal cell lines.
    Ouali F; Djouadi F; Bastin J
    Am J Physiol Renal Physiol; 2002 Aug; 283(2):F328-34. PubMed ID: 12110517
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fatty acid utilization in the hypertrophied and failing heart: molecular regulatory mechanisms.
    Barger PM; Kelly DP
    Am J Med Sci; 1999 Jul; 318(1):36-42. PubMed ID: 10408759
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of hypoxia on MnSOD expression in mouse lung.
    Russell WJ; Ho YS; Parish G; Jackson RM
    Am J Physiol; 1995 Aug; 269(2 Pt 1):L221-6. PubMed ID: 7653584
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling.
    Yoshikawa T; Ide T; Shimano H; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Yatoh S; Kitamine T; Okazaki H; Tamura Y; Sekiya M; Takahashi A; Hasty AH; Sato R; Sone H; Osuga J; Ishibashi S; Yamada N
    Mol Endocrinol; 2003 Jul; 17(7):1240-54. PubMed ID: 12730331
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro and in vivo consequences of variant medium-chain acyl-CoA dehydrogenase genotypes.
    Touw CM; Smit GP; Niezen-Koning KE; Bosgraaf-de Boer C; Gerding A; Reijngoud DJ; Derks TG
    Orphanet J Rare Dis; 2013 Mar; 8():43. PubMed ID: 23509891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.